These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1513861

  • 1. Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.
    Castellano C, Battaglia M, Sansone M.
    Pharmacol Biochem Behav; 1992 Aug; 42(4):797-801. PubMed ID: 1513861
    [Abstract] [Full Text] [Related]

  • 2. Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice.
    Sansone M, Castellano C, Battaglia M, Ammassari-Teule M.
    Pharmacol Biochem Behav; 1990 Jun; 36(2):389-92. PubMed ID: 2356212
    [Abstract] [Full Text] [Related]

  • 3. Effects of oxiracetam, physostigmine, and their combination on active and passive avoidance learning in mice.
    Sansone M, Castellano C, Palazzesi S, Battaglia M, Ammassari-Teule M.
    Pharmacol Biochem Behav; 1993 Feb; 44(2):451-5. PubMed ID: 8446678
    [Abstract] [Full Text] [Related]

  • 4. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.
    Sansone M, Battaglia M, Vetulani J.
    Pol J Pharmacol; 1995 Feb; 47(1):69-73. PubMed ID: 7550552
    [Abstract] [Full Text] [Related]

  • 5. Interaction between nootropic drugs and methamphetamine on avoidance acquisition but not on locomotor activity in mice.
    Sansone M, Ammassari-Teule M, Oliverio A.
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):229-35. PubMed ID: 4096612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
    Ammassari-Teule M, Castellano C, Sansone M.
    Behav Brain Res; 1992 Mar 15; 47(1):93-5. PubMed ID: 1571105
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G, Spignoli G, Giovannini MG, Magnani M.
    Pharmacopsychiatry; 1989 Oct 15; 22 Suppl 2():116-9. PubMed ID: 2602443
    [Abstract] [Full Text] [Related]

  • 17. Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.
    Paoli F, Spignoli G, Pepeu G.
    Psychopharmacology (Berl); 1990 Oct 15; 100(1):130-1. PubMed ID: 2153307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.